Home Page>MFG & Quality>Our Manufacturing Base>Specialty TCM Base>text

Tianchang Yifan Pharmaceutical

Special Chinese patent drugs manufacture base

Tianchang Yifan Pharmaceutical is a high-tech enterprise specializing in the production of Chinese patent medicines for more than two decades, with an annual production capacity of about 15 million boxes in 43 varieties.
Adopting a high starting point approach for its factory construction, the company introduced domestically leading drug production and testing equipment, and became the first drug manufacturer in Anhui Province that fully passed the national GMP acceptance check on March 21, 2000. At present, the company has multiple production lines for granules, tablets, capsules, mixtures (oral liquid), guttate pills, etc. Starting with common diseases and frequently occurring diseases, the New Drug R&D Department of the company has successively launched new products, and constantly developed its own flagship products: Compound Realgar Natural Indigo Tablets, a special drug for treating acute promyelocytic leukemia. A researcher of the company Professor Huang Shilin received an order of commendation from President Jiang Zemin on June 27, 2002, and won the second prize of the National Science and Technology Progress Award in November 2011. In addition, Compound Yinhua Detoxicating Granules of the company, a national second-class protected TCM variety, has been accredited as a National Innovation Fund Project; and its Maqin Cough-relieving Granules for acute and chronic tracheitis, Yandan Capsules for cardiovascular and cerebrovascular diseases, and Hawthorn Essence Lipid Lowering Dropping Pills for hyperlipidemia, have been accredited as exclusive national Class III new drugs. Apart from the new special-effect drugs above, the company also produces a large number of products having huge market potential and unique curative effect, such as Stasis-dissolving and Freckle Removing Capsules, which is a beauty product having code number approved by NMPA, as well as Fuyan Kangfu Granules for obstetrical and gynecological diseases, and Xinshenghua Granules. In addition, the company has more than 20 provincial bid-winning varieties, drugs on the National Medical Insurance Reimbursement List, and those on the National Essential Drugs List, such as Ganmaoling Granules, Weishuning Granules, Huanglian Shangqing Tablets, Yangxue Anshen Tablets, Yuanhu Pain-relieving Capsules, which belong to general drugs. The product line structure of the company is being constantly enriched.

Contact our Pharmacovigilance